The observed cross-reactive effects of CD4+ and CD8+ T cells may be of importance in swift and effective viral clearance of SARS-CoV-2, reducing the severity of symptoms in COVID-19 patients pre-vaccinated with BCG. This evidence concerns the gene CD4 and COVID-19.